Sage Therapeutics
SAGE
#6961
Rank
C$0.74 B
Marketcap
C$11.83
Share price
0.00%
Change (1 day)
3.00%
Change (1 year)

EPS for Sage Therapeutics (SAGE)

EPS in 2025 (TTM): C-$6.92

According to Sage Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$6.86. In 2022 the company made an earnings per share (EPS) of C-$12.24 a decrease over its 2021 EPS that were of C-$10.63.

EPS history for Sage Therapeutics from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$6.92
2022C-$12.2415.13%
2021C-$10.63-167.18%
2020C$15.83-186.77%
2019C-$18.2466.21%
2018C-$10.9813.06%
2017C-$9.7151.49%
2016C-$6.4138.64%
2015C-$4.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Regulus Therapeutics
RGLS
C-$1.00-85.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
C-$2.02-70.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
C$2.62-138.17%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eagle Pharmaceuticals
EGRX
C$1.62-123.66%๐Ÿ‡บ๐Ÿ‡ธ USA